JPRN-UMIN000023944
Completed
未知
Best Beta-Blocker in Systolic Heart Failure, analysis of prognosis and evaluation of therapies - B-cube SHF trial
Chiba-Nishi General Hospital Cardiology0 sites400 target enrollmentSeptember 7, 2016
Conditionssystolic heart failure
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- systolic heart failure
- Sponsor
- Chiba-Nishi General Hospital Cardiology
- Enrollment
- 400
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\)patients who are considered not to be candidate for administration of beta blocker. 2\)patients who are scheduled to undergo emergent dialysis or chronic dialysis patients. 3\)patients who have developed acute coronary syndrome within 8 weeks before the registration day. 4\)patients who need mechanical hemodynamical support (except for pace maker implantation OR ICD) 5\)patients who have malignancy within 1 year prognosis. 6\)patients who are pregnant, lactating, may become pregnant, or want to become pregnant during the study. 7\)patients who are judged by an investor to be inappropriate for this study for any other reason.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
Beta 3 agonist treatment in heart failure (BEAT-HF)EUCTR2012-004805-29-DKThe Heart Center, Rigshospitalet85
Active, not recruiting
Phase 1
Beta 3 agonist treatment in heart failure (BEAT-HF II)Heart FailureMedDRA version: 19.0Level: LLTClassification code 10019279Term: Heart failureSystem Organ Class: 100000004849Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]EUCTR2016-002367-34-DKHjertemedicinsk klinik, Rigshospitalet70
Completed
Phase 3
Beta-Blocker Evaluation in Survival Trial (BEST)Cardiovascular DiseasesHeart DiseasesHeart Failure, CongestiveHeart FailureNCT00000560National Heart, Lung, and Blood Institute (NHLBI)
Terminated
Phase 4
BOAT: Beta Blocker Uptitration With OptiVol After Cardiac Resynchronization Therapy (CRT)Congestive Heart FailureNCT00433043St. Luke's-Roosevelt Hospital Center2
Recruiting
Phase 2
Beta-Blocker Withdrawal in Heart Failure with Preserved Ejection Fraction and Chronotropic Incompetence (BRILLIANT)JPRN-jRCT1031210030Obokata Masaru150